Pacific Biosciences of California, Inc. (PACB)

PACB Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	56.47	55.37	179.91	325.09	460.73	81.61
Short-Term Investments	242.19	334.56	451.51	447.23	583.68	237.2
Cash & Short-Term Investments	298.65	389.93	631.42	772.32	1,044	318.81
Cash Growth	-36.61%	-38.25%	-18.24%	-26.05%	227.59%	549.33%
Accounts Receivable	30.62	27.52	36.62	18.79	24.24	16.84
Receivables	30.62	27.52	36.62	18.79	24.24	16.84
Inventory	53.15	58.76	56.68	50.38	24.6	14.23
Prepaid Expenses	11.51	14.78	17.04	10.29	7.39	4.87
Restricted Cash	0.3	0.69	0.3	0.3	0.5	0.84
Other Current Assets	-	4	-	-	-	-
Total Current Assets	394.24	495.68	742.05	852.07	1,101	355.59
Property, Plant & Equipment	64.71	46.6	69.03	81.34	79.12	54.85
Goodwill	317.76	317.76	462.26	409.97	409.97	-
Other Intangible Assets	16.14	389.57	456.98	410.25	410.98	-
Other Long-Term Assets	10.31	10.84	15.7	13.45	5.76	3.54
Total Assets	803.16	1,260	1,746	1,767	2,007	413.98
Accounts Payable	16.36	16.59	15.06	12.03	11	3.58
Accrued Expenses	26.17	21.51	44.74	34.58	39.27	19.23
Current Portion of Long-Term Debt	3	-	0.49	1.84	1.61	-
Current Portion of Leases	0.62	10.03	9.59	8.89	7.71	4.33
Current Unearned Revenue	16.05	13.86	16.34	30.5	10.98	8.72
Other Current Liabilities	1.01	4.31	8.8	175.5	1.15	2.64
Total Current Liabilities	63.21	66.3	95.03	263.34	71.71	38.5
Long-Term Debt	645.16	647.49	892.24	896.68	896.07	-
Long-Term Leases	54.3	14.91	31.61	41.07	49.97	37.67
Long-Term Unearned Revenue	4.4	5.9	5.53	1.79	25.05	1.57
Other Long-Term Liabilities	-	19.25	20.3	1.3	173.19	0.75
Total Liabilities	767.07	753.85	1,045	1,204	1,216	78.49
Common Stock	0.3	0.29	0.27	0.23	0.22	0.19
Additional Paid-In Capital	2,690	2,655	2,540	2,100	2,010	1,372
Retained Earnings	-2,655	-2,149	-1,839	-1,532	-1,218	-1,037
Comprehensive Income & Other	0.42	0.42	0.22	-4.77	-1.09	0.09
Shareholders' Equity	36.09	506.59	701.3	562.9	790.99	335.49
Total Liabilities & Equity	803.16	1,260	1,746	1,767	2,007	413.98
Total Debt	703.08	672.43	933.93	948.48	955.36	42
Net Cash (Debt)	-404.43	-282.5	-302.51	-176.16	89.05	276.82
Net Cash Growth	-	-	-	-	-67.83%	-
Net Cash Per Share	-1.37	-1.03	-1.19	-0.78	0.44	1.58
Filing Date Shares Outstanding	301.91	297.85	267.95	247.08	221.18	193.1
Total Common Shares Outstanding	301.85	294.42	267.74	226.51	220.98	192.29
Working Capital	331.03	429.38	647.02	588.74	1,029	317.09
Book Value Per Share	0.12	1.72	2.62	2.49	3.58	1.74
Tangible Book Value	-297.81	-200.74	-217.94	-257.32	-29.97	335.49
Tangible Book Value Per Share	-0.99	-0.68	-0.81	-1.14	-0.14	1.74
Machinery	-	69.13	68.03	60.86	49.8	39.78
Construction In Progress	-	2.28	1.34	4.7	2.3	0.14
Leasehold Improvements	-	33.77	35.23	34.13	31.11	29.93
Order Backlog	-	31.2	18.7	-	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q